Welcome to our dedicated page for Senseonics SEC filings (Ticker: SENS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Senseonics finances next-generation Eversense implants isn’t simple—its 10-K spreads clinical-trial data, FDA milestones, and convertible-note terms across 200+ pages, while each quarterly 10-Q reshapes gross-margin outlooks. Investors asking “What does Senseonics report in their SEC filings?� or searching for “Senseonics insider trading Form 4 transactions� often face dense medical-device language that slows decisive action.
Stock Titan removes that friction. Our AI reviews every Senseonics annual report 10-K simplified, each Senseonics quarterly earnings report 10-Q filing, and all Senseonics 8-K material events explained, then delivers clear, plain-English summaries. Need “Senseonics Form 4 insider transactions real-time�? You’ll get instant alerts the second an executive files. It’s the fastest route for understanding Senseonics SEC documents with AI-driven clarity—no footnote digging required.
We connect filing types to the factors that truly drive this med-tech innovator. Use the 10-K and 10-Q to trace Eversense production costs, partnership revenue with Ascensia, and risk factors tied to long-term sensor accuracy. Dive into the proxy statement executive compensation section to see how milestone-based bonuses align with FDA approvals. Monitor executive stock transactions Form 4 to gauge insider confidence, and compare data across quarters with our “Senseonics earnings report filing analysis� tool. Whether you’re modeling cash burn or evaluating dilution, Stock Titan’s AI-powered summaries, real-time updates, and complete coverage make Senseonics SEC filings explained simply.
Senseonics Holdings, Inc. (SENS) is asking shareholders to approve authority for its board to implement a reverse stock split at a ratio between 1-for-10 and 1-for-20, at any time before September 29, 2026. The Special Meeting will be held virtually on September 29, 2025 and the record date is August 7, 2025 when 814,680,910 shares were outstanding. The board unanimously recommends a vote FOR the proposal to give management flexibility to raise the per-share trading price, address NYSE American minimum price criteria, potentially improve marketability and liquidity, and preserve flexibility for future corporate actions. No fractional shares will be issued; holders entitled to fractions will receive cash based on the five-day average closing price before the effective date. Approval requires a majority of votes properly cast.
Senseonics Holdings, Inc. reported that Robert J. Smith and affiliated entities beneficially own a combined 50,035,000 shares of common stock, equal to 6.14% of the class. That aggregate position is composed of holdings by Energy Capital, LLC (49,700,000 shares, 6.10%) and Plato & Associates, LLC (335,000 shares, 0.04%).
The filing states Mr. Smith has sole voting and sole dispositive power over the reported shares, meaning he alone can direct voting and disposition of the position. The statement includes a certification that the securities were not acquired to change or influence control of the issuer.
Senseonics Holdings (NYSE American: SENS) has filed a Form S-3 universal shelf. The registration enables the company to issue up to $300 million in any mix of common or preferred stock, debt securities and warrants. It also includes a $100 million at-the-market (ATM) program with TD Cowen; unsold ATM capacity can be re-allocated to other offerings.
SENS is a non-accelerated, smaller reporting company with 814.7 million shares outstanding and a recent share price of $0.51 (5 Aug 2025). Proceeds are earmarked for general corporate purposes—R&D, SG&A, commercialization of the Eversense implantable CGM platform, capex and potential acquisitions—though no commitments are specified.
The filing contains no new operating results, but it signals that management may raise capital equal to roughly one-third of the current market capitalization, creating potential dilution while enhancing liquidity and strategic flexibility.
Senseonics Holdings, Inc. (NYSE American: SENS) filed a Form 8-K dated August 6, 2025 under Item 2.02 to furnish a press release (Exhibit 99.1) announcing its results for the quarter ended June 30, 2025. The press release also provides details for an accompanying conference call covering recent corporate highlights and the Company’s outlook. In accordance with SEC rules, the furnished material is not deemed “filed� for liability purposes and will not be incorporated by reference into other SEC filings. No quantitative financial data, guidance figures, or strategic updates are included in the 8-K itself.
FAQ
What is the current stock price of Senseonics (SENS)?
What is the market cap of Senseonics (SENS)?
